Cellectar Biosciences, Inc. Profile Avatar - Palmy Investing

Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), whic…

Biotechnology
US, Florham Park [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of CLRB's Analysis
CIK: 1279704 CUSIP: 15117F500 ISIN: US15117F8077 LEI: - UEI: -
Secondary Listings
CLRB has no secondary listings inside our databases.